Atik Alp

Comparative Cost-effectiveness of Trabeculectomy versus MicroShunt in the US Medicare System.

Trabeculectomy appears to be a dominant treatment strategy over the MicroShunt in the surgical management of glaucoma.

Prospective, Randomized Controlled Trial of Cataract Surgery vs Combined Cataract Surgery With Insertion of iStent Inject.

Combined cataract surgery with iStent Inject achieved a clinically- and statistically-significantly greater reduction in ocular hypotensive medication usage at 24-months compared to cataract surgery alone, with no significant difference in IOP.

Comparison between surgical outcomes of glaucoma drainage implant surgery performed with and without intraluminal stent.

Cost Utility of Schlemm's Canal Microstent Injection With Cataract Surgery for Open-angle Glaucoma in the US Medicare System.

HMS implantation during cataract surgery appears to be cost-effective for patients with mild-to-moderate glaucoma. Nevertheless, more long-term safety and efficacy data are required.

Re: Van Lancker et al.: Clinical outcomes and cost analysis of PreserFlo versus trabeculectomy for glaucoma management in the United Kingdom (Ophthalmol Glaucoma. 2023;6:342-357).

Response to Letter to the Editor: Cost Utility of Schlemm Canal Microstent Injection With Cataract Surgery for Open Angle Glaucoma in the US Medicare System.

Cardiovascular effects and safety of mannitol in treating raised intraocular pressure.